IP Library Assignment 033782/0221
Patent Assignment
Reel/Frame 033782/0221

Merger and Change of Name

Recorded: 2014-09-19 Pages: 4
Assignors
ANORMED INC.
Executed: 2006-11-17
DEMATAL CORP.
Executed: 2006-11-17
Assignee
ANORMED CORPORATION
NO. 200- 20353 64TH AVENUE, LANGLEY, V2Y 1N5, CANADA
Covered Properties (23)
Aromatic-Linked Polyamine Macrocyclic Compounds with Anti-Hiv Activity
Patent: 5,583,131 →
Application: 08/244,863 →
Process for Preparing 1,1'-[1,4-Phenylenebis-(Methylene)]- Bis-1,4,8,11-Tetraazacyclotetradecane
Patent: 5,612,478 →
Application: 08/413,582 →
Antiviral Compounds
Patent: 5,817,807 →
Application: 08/659,500 →
Cyclic Polyamines
Patent: 5,698,546 →
Application: 08/669,279 →
Antiviral Compounds
Patent: 6,506,770 →
Application: 09/111,895 →
Methods to enhance white blood cell count
Patent: 6,365,583 →
Application: 09/495,298 →
Chemokine Receptor Binding Heterocyclic Compounds
Patent: 6,667,320 →
Application: 09/740,050 →
Publication: US 2002/0077339
Methods to Mobilize Progenitor/Stem Cells
Patent: 6,987,102 →
Application: 10/209,001 →
Publication: US 2003/0130250
Methods to Mobilize Progenitor/Stem Cells
Patent: 7,169,750 →
Application: 10/456,942 →
Publication: US 2005/0043367
Chemokine Receptor Binding Heterocyclic Compounds with Enhanced Efficacy
Patent: 7,354,932 →
Application: 10/457,034 →
Publication: US 2004/0019058
Chemokine Receptor Binding Heterocyclic Compounds
Patent: 7,022,717 →
Application: 10/703,781 →
Publication: US 2004/0102428
CXCR4 Chemokine Receptor Binding Compounds
Patent: 7,291,631 →
Application: 10/823,494 →
Publication: US 2004/0209921
Chemokine Receptor Binding Heterocyclic Compounds with Enhanced Efficacy
Patent: 7,550,484 →
Application: 10/831,098 →
Publication: US 2005/0059702
Synthesis of Enantiomerically Pure Amino-Substituted Fused Bicyclic Rings
Patent: 7,135,570 →
Application: 10/959,823 →
Publication: US 2005/0080267
Methods of Making 2,6-Diaryl Piperidine Derivatives
Patent: 7,501,518 →
Application: 10/977,221 →
Publication: US 2005/0154201
Process for the Synthesis of CXCR4 Antagonist
Patent: 7,332,605 →
Application: 11/077,896 →
Publication: US 2005/0209277
Chemokine-Binding Heterocyclic Compound Salts, and Methods of Use Thereof
Patent: 7,723,525 →
Application: 11/235,469 →
Publication: US 2006/0069122
Methods to Mobilize Progenitor/Stem Cells
Patent: 7,935,692 →
Application: 11/269,773 →
Publication: US 2006/0193826
Chemokine Receptor Binding Heterocyclic Compounds with Enhanced Efficacy
Patent: 7,354,934 →
Application: 11/301,725 →
Publication: US 2006/0100240
Synthesis of Enantiomerically Pure Amino-Substituted Fused Bicyclic Rings
Patent: 7,452,994 →
Application: 11/598,955 →
Publication: US 2007/0060757
CXCR4 Chemokine Receptor Binding Compounds
Patent: 7,863,293 →
Application: 11/936,047 →
Publication: US 2008/0255197
Aromatic-Linked Polyamine Macrocyclic Compounds with Anti-Hiv Activity
Patent: 42,152 →
Application: 12/192,704 →
Chemokine Receptor Binding Heterocyclic Compounds with Enhanced Efficacy
Patent: 8,778,967 →
Application: 13/358,041 →
Publication: US 2012/0301427
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2014
From: MCEACHERN, ERNEST J.; SKUPINSKA, KRYSTYNA A.; BRIDGER, GARY J.; SKERLJ, RENATO T.
To: ANORMED, INC.
Reel/Frame 033779/0723 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 013411 Frame 0065. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Anormed, Inc. Sep 24, 2014
From: BRIDGER, GARY J.; ABRAMS, MICHAEL J.; HENSON, GEOFFREY W.; MACFARLAND, RONALD TREVOR
To: ANORMED, INC.
Reel/Frame 033813/0558 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 014372 Frame: 0636. Assignor(S) Hereby Confirms the Assignment. Sep 26, 2014
From: BRIDGER, GARY J.; ABRAMS, MICHAEL J.; HENSON, GEOFFREY W.; MACFARLAND, RONALD TREVOR
To: ANORMED, INC.
Reel/Frame 033831/0486 →